SBC Medical Group Holdings Incorporated filed a current report on November 13, 2026, announcing its financial results for the quarter ended September 30, 2026, alongside a posted investor presentation covering the same period.

Key Highlights

  • Reporting period: Results cover the quarter ended September 30, 2026.
  • Press release attached: Exhibit 99.1, titled "SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results," is incorporated by reference.
  • Investor presentation posted: A "3Q 2026 Investor Presentation" providing an overview of the company's business and quarterly results was posted to the company's investor relations website.
  • Emerging growth company: The company has indicated it qualifies as an emerging growth company under applicable SEC rules.
  • Signed by CFO and COO: Yuya Yoshida, Chief Financial Officer and Chief Operating Officer, signed the filing on November 13, 2026.

SBC Medical Group Holdings Files 8-K for Third Quarter 2026 Operations

SBC Medical Group Holdings Incorporated, a Delaware-incorporated company trading on NASDAQ:SBC with its principal offices at 200 Spectrum Center Dr., Suite 300, Irvine, California, filed this current report under Item 2.02, which covers results of operations and financial condition. The filing discloses that the company issued a press release on November 13, 2026, announcing third quarter 2026 financial results, with the press release attached as Exhibit 99.1 and incorporated by reference into the filing.

The company also made disclosures under Item 7.01, the Regulation FD provision, noting that it posted a "3Q 2026 Investor Presentation" to its investor relations website on the same date. According to the filing, the company periodically uses its website to distribute information to investors, including regulatory filings made available as soon as reasonably practicable after electronic submission. The filing states that "the information that the Company posts on its website may be deemed material" and encourages investors to monitor the website alongside press releases, regulatory filings, conference calls, and the company's LinkedIn page.

The filing notes that information furnished under Items 2.02 and 7.01, including the attached press release and the investor presentation, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, and is not subject to the liabilities under that section. The company also holds redeemable warrants listed on NASDAQ under the symbol SBCWW, with each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share, as stated on the filing's cover page.

What Was Disclosed

SBC Medical Group Holdings Incorporated reported its third quarter 2026 results via an attached press release and an investor presentation posted to its website, both dated November 13, 2026. The current report was signed by Chief Financial Officer and Chief Operating Officer Yuya Yoshida.